Upstream Bio, Inc. UPB
NASDAQ Price as of Nov 10, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Jun 30, 2026
Market cap
$184.58M
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
-17.5%
EPS growth YoY
1.4%
ROIC
-53.2%
Piotroski F-score
3
Three ways to read the P/E
P/E (GAAP, TTM)
—
Net income of the last 4 quarters. Includes investment gains and one-time items.
P/E (GAAP, annual)
—
Net income of the latest fiscal year. Includes investment gains and one-time items.
P/E (operating)
—
After-tax operating income only: the core business.
P/E (excl. gains)
—
Net income after removing identified investment and asset-sale gains.
How it has changed
Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.
| Metric | 2026Q3 | 2026Q2 | Change QoQ | 2025Q3 | Change YoY |
|---|---|---|---|---|---|
| Revenue growth YoY (qtr) | -17.5% | 82.7% | -100.2 pts | 83.7% | -101.2 pts |
| EPS growth YoY (qtr) | 1.4% | -47.1% | +48.4 pts | 88.6% | -87.3 pts |
| Revenue growth (TTM) | 16.0% | 44.7% | -28.7 pts | — | — |
| EPS growth (TTM) | -166.4% | -105.7% | -60.8 pts | — | — |
| P/E (GAAP, TTM) | — | — | — | — | — |
| P/E (operating) | — | — | — | — | — |
| P/E (excl. gains) | — | — | — | — | — |
| P/B | 0.83 | 1.10 | -0.26 | — | — |
| ROIC | -53.2% | -53.2% | 0.0 pts | -42.7% | -10.5 pts |
| Net margin | -5,026.0% | -5,026.0% | 0.0 pts | -2,650.0% | -2,376.0 pts |
| Dividend yield | 0.0% | 0.0% | 0.0 pts | — | — |
| EPS (TTM) | -2.89 | -2.90 | +0.3% | 4.35 | -166.4% |
| Price | $5.26 | $6.92 | -24.0% | — | — |
History by quarter-end
Reported quarters
| Quarter ended | Revenue | QoQ | YoY | EPS | QoQ | YoY | Net margin |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | $773.00K | -25.2% | -17.5% | -0.73 | 2.7% | 1.4% | -5,136.1% |
| Mar 31, 2026 | $1.03M | 54.8% | 82.7% | -0.75 | 3.8% | -47.1% | -3,925.6% |
| Dec 31, 2025 * | $668.00K | -2.2% | 9.0% | -0.78 | -23.8% | -106.2% | -6,356.1% |
| Sep 30, 2025 | $683.00K | -27.1% | 12.5% | -0.63 | 14.9% | 90.9% | -4,941.1% |
| Jun 30, 2025 | $937.00K | 65.5% | 83.7% | -0.74 | -45.1% | 88.6% | -4,265.3% |
| Mar 31, 2025 | $566.00K | -7.7% | -11.6% | -0.51 | -104.1% | 89.1% | -4,818.0% |
| Dec 31, 2024 * | $613.00K | 1.0% | — | 12.56 | 280.5% | — | -3,465.3% |
| Sep 30, 2024 | $607.00K | 19.0% | -2.3% | -6.96 | -7.1% | -229.9% | -2,634.6% |
| Jun 30, 2024 | $510.00K | -20.3% | — | -6.50 | -38.9% | — | -2,878.0% |
| Mar 31, 2024 | $640.00K | — | — | -4.68 | — | — | -1,702.2% |
| Dec 31, 2023 * | — | — | — | — | — | — | — |
| Sep 30, 2023 | $621.00K | — | — | -2.11 | — | — | -499.5% |
* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.
All figures
Price & size
| Fiscal year end | Dec 31, 2025 | End date of the latest annual (10-K) report used. |
|---|---|---|
| Price date | Nov 10, 2026 | Date of the latest closing price used. |
| Price | $3.37 | Latest closing price. |
| Market cap | $184.58M | Price × shares outstanding. |
| Enterprise value | $83.00M | Market cap + debt − cash: the price of the whole business. |
| Shares | 54.77M | Shares outstanding used for market cap. |
Valuation
| P/E (GAAP, annual) | — | Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative. |
|---|---|---|
| P/E (GAAP, TTM) | — | Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items. |
| P/E (operating) | — | Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items. |
| P/E (operating, TTM) | — | Market cap ÷ after-tax operating income of the last four quarters. |
| P/E (excl. gains) | — | Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified. |
| PEG | — | P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap. |
| PEG (TTM) | — | TTM P/E ÷ TTM EPS growth rate (in %). |
| Earnings yield | -77.7% | Net income ÷ market cap. The inverse of the P/E. |
| Earnings yield (TTM) | -85.8% | TTM EPS ÷ price. |
| P/B | 0.54 | Market cap ÷ shareholders' equity. Blank when equity is negative. |
| P/S | 64.67 | Market cap ÷ revenue of the latest fiscal year. |
| P/S (TTM) | 58.45 | Market cap ÷ revenue of the last four quarters. |
| P/FCF | — | Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative. |
| EV/EBITDA | — | Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels. |
| EV/EBIT | — | Enterprise value ÷ operating income. |
| EV/Sales | 29.08 | Enterprise value ÷ revenue. |
| Book value / share | 6.20 | Shareholders' equity ÷ shares. |
| FCF yield | -72.3% | Free cash flow ÷ market cap. |
Operating vs. one-time earnings
| Operating EPS | -2.31 | After-tax operating income per share (latest fiscal year). |
|---|---|---|
| Investment gains | — | Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified. |
| Asset-sale gains | — | One-time gains or losses from selling property, assets or businesses. Blank = none identified. |
| Non-operating income | — | Pre-tax income minus operating income: interest, investment results and one-time items combined. |
| Gains as % of net income | 0.0% | Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains. |
Latest quarter & trailing 12 months
| Latest quarter | Jun 30, 2026 | End date of the most recent reported quarter. |
|---|---|---|
| Revenue (qtr) | $773.00K | Revenue of the latest reported quarter. |
| Net income (qtr) | -$39.70M | Net income of the latest reported quarter. |
| EPS (qtr) | -0.73 | Diluted EPS of the latest reported quarter. |
| Revenue growth YoY (qtr) | -17.5% | Latest quarter revenue vs the same quarter a year earlier. |
| Revenue growth QoQ (qtr) | -25.2% | Latest quarter revenue vs the previous quarter. |
| EPS growth YoY (qtr) | 1.4% | Latest quarter EPS vs the same quarter a year earlier. |
| EPS growth QoQ (qtr) | 2.7% | Latest quarter EPS vs the previous quarter. |
| Net income growth YoY (qtr) | 0.7% | Latest quarter net income vs the same quarter a year earlier. |
| Net income growth QoQ (qtr) | 2.2% | Latest quarter net income vs the previous quarter. |
| Gross margin (qtr) | — | Gross profit ÷ revenue in the latest quarter. |
| Operating margin (qtr) | -5,481.0% | Operating income ÷ revenue in the latest quarter. |
| Net margin (qtr) | -5,136.1% | Net income ÷ revenue in the latest quarter. |
| Revenue (TTM) | $3.16M | Revenue of the last four quarters. |
| Net income (TTM) | -$156.50M | Net income of the last four quarters. |
| EPS (TTM) | -2.89 | Sum of the last four quarters of diluted EPS. |
| Revenue growth (TTM) | 16.0% | Last four quarters of revenue vs the four quarters before. |
| EPS growth (TTM) | -166.4% | Last four quarters of EPS vs the four quarters before. |
| Net income growth (TTM) | -49.8% | Last four quarters of net income vs the four quarters before. |
Dividends & shareholder returns
| Dividend yield | 0.0% | Dividends paid per share over the last 12 months ÷ price. |
|---|---|---|
| Dividend / share (TTM) | — | Dividends per share paid over the last 12 months. |
| Payout ratio | — | Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings. |
| FCF payout ratio | — | Dividends ÷ free cash flow. |
| Dividend growth (1y) | — | Dividends per share vs the same 12-month window a year earlier. |
| Dividend CAGR (3y) | — | Annualised dividend growth over 3 years. |
| Dividend CAGR (5y) | — | Annualised dividend growth over 5 years. |
| Payments (12m) | — | Number of dividend payments in the last 12 months. |
| Last ex-dividend date | — | Most recent ex-dividend date. |
| Buyback yield | 0.0% | Share repurchases ÷ market cap. |
| Shareholder yield | 0.0% | Dividend yield + buyback yield. |
Profitability
| Gross margin | — | Gross profit ÷ revenue (latest fiscal year). |
|---|---|---|
| EBITDA margin | -5,612.2% | EBITDA ÷ revenue. |
| Operating margin | -5,618.8% | Operating income ÷ revenue. |
| Net margin | -5,026.0% | Net income ÷ revenue. |
| FCF margin | -4,675.5% | Free cash flow ÷ revenue. |
| ROE | -42.2% | Return on equity: net income ÷ shareholders' equity. Blank when equity is negative. |
| ROA | -40.5% | Return on assets: net income ÷ total assets. |
| ROIC | -53.2% | Return on invested capital: after-tax operating income ÷ (equity + debt − cash). |
Growth (annual)
| Revenue growth (annual) | 20.4% | Latest fiscal year revenue vs the year before. |
|---|---|---|
| Net income growth (annual) | -128.4% | Latest fiscal year net income vs the year before. |
| EPS growth (annual) | 52.3% | Latest fiscal year diluted EPS vs the year before. |
| Revenue CAGR (3y) | — | Annualised revenue growth over 3 fiscal years. |
| EPS CAGR (3y) | — | Annualised EPS growth over 3 fiscal years. |
Financial health
| Current ratio | 26.15 | Current assets ÷ current liabilities. Above 1 means short-term bills are covered. |
|---|---|---|
| Quick ratio | 26.15 | (Current assets − inventory) ÷ current liabilities. |
| Cash ratio | 7.55 | Cash ÷ current liabilities. |
| Debt / equity | 0.00 | Total debt ÷ shareholders' equity. Blank when equity is negative. |
| Debt / assets | 0.00 | Total debt ÷ total assets. |
| Debt / EBITDA | — | Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt. |
| Net debt / EBITDA | — | (Debt − cash) ÷ EBITDA. Negative means more cash than debt. |
| Interest coverage | — | Operating income ÷ interest expense. |
Earnings quality
| FCF conversion | — | Free cash flow ÷ net income. Above 100% means profits turn into real cash. |
|---|---|---|
| Accruals ratio | -2.9% | (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings. |
| Stock comp % revenue | 362.0% | Share-based compensation ÷ revenue. |
| R&D % revenue | 4,793.5% | Research & development spending ÷ revenue. |
| SG&A % revenue | — | Selling, general & administrative expense ÷ revenue. |
| Tax rate used | 21.0% | Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown). |
Efficiency
| Asset turnover | 0.01 | Revenue ÷ total assets. |
|---|---|---|
| Days sales outstanding | 85 | Average days to collect payment from customers. |
| Days inventory | — | Average days inventory is held. |
| Days payables | — | Average days to pay suppliers. |
Trading & momentum
| 52-week high | $46.12 | Highest price in the last 52 weeks. |
|---|---|---|
| 52-week low | $2.68 | Lowest price in the last 52 weeks. |
| From 52-week high | -92.7% | How far below the 52-week high the price is (0% = at the high). |
| Above 52-week low | 25.7% | How far above the 52-week low the price is. |
| Avg volume (30d) | 951.25K | Average shares traded per day over the last 30 days. |
| Avg $ volume (30d) | $3.02M | Average dollars traded per day over the last 30 days: a liquidity measure. |
Scores
| Piotroski F-score | 3 | Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail. |
|---|---|---|
| Altman Z-score | 6.25 | Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers. |
Reported figures (latest fiscal year)
| Revenue | $2.85M | Revenue of the latest fiscal year. |
|---|---|---|
| Net income | -$143.44M | Net income of the latest fiscal year. |
| Diluted EPS | -2.66 | Diluted earnings per share of the latest fiscal year. |
| EBITDA | -$160.17M | Operating income + depreciation & amortization. |
| Free cash flow | -$133.44M | Operating cash flow − capital spending. |
| Total debt | $0 | Long-term plus current debt. |
| Cash | $101.58M | Cash and equivalents. |
| Equity | $339.77M | Shareholders' equity. |
| Total assets | $353.77M | Total assets. |